NVO stock has been spiraling in recent months, shedding 39% since its Aug. 1 peak at $57.41. Short sellers have been targeting the equity for more losses, too. However, although short interest on NVO spiked 77.4% in the two most recent …
and many are still untreated.Novo Nordisk caught the wave early, and claims a 46% share of the global insulin market. The company's earnings per share and dividends paid have increased more than fivefold over the past decade, but the …
Novo Nordisk’s B shares are listed on the stock exchanges in Copenhagen and London. Its ADRs are listed on the New York Stock Exchange under the symbol ‘NVO’. For more information, visit novonordisk.com. ZymoGenetics Forward …
People forget, they had Apidra, which competes against Lilly and Novo Nordisk, and they didn't succeed with that ... What would you say to either existing …
Novo Nordisk, which plans to build a $1.2 billion manufacturing plant in Johnson County, has received U.S. Food and Drug Administration (FDA) approval to market two new diabetes drugs. Its stock saw a bounce on the news....
COPENHAGEN, March 21 (Reuters) - Denmark’s Novo Nordisk , the world’s biggest insulin producer, will consider a stock split when its shares approach a level of 1,000 Danish crowns ($180) per share, the company’s chairman told …
ZymoGenetics, Inc. (NASDAQ: ZGEN) has filed an SEC registration which would allow the company to sell up to $100 million of its common stock from time to time. What is important to note is that this is intended to replace the …
Shares of Danish drug maker Novo Nordisk fell more than 4% Monday after a J.P. Morgan analyst downgraded the company’s stock on concerns its Tresiba insulin medication sales might be compromised by regulatory holdups. …
This week, fast-food king-pin McDonald’s (NYSE:MCD) unveiled in Japan its newest creation- Mega Fries. The three-quarters of a pound, 1142 calorie serving of french fries- while potentially delicious- underscores that our new diet of …